Locally Advanced Unresectable Primary Central Chondrosarcoma
1 clinical trials · Condition
◉ Watch Locally Advanced Unresectable Primary Central Chondrosarcoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma (NCT04340843) | National Cancer Institute (NCI) | 2020-09-08 |
Track Locally Advanced Unresectable Primary Central Chondrosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.